Clinical Nursing Sample Clauses

Clinical Nursing. 4.2.1 Carries out comprehensive and accurate nursing assessment of patients, plan and implement care and evaluate the achievement of identified outcomes:  Uses a structured approach in the process of assessment and collection of data regarding the health and functional status of the patient.  Analyses and interprets the data accurately.  Collaborates with the patient and family/carers/significant other in identifying expected health care outcomes and patient needs.  Formulates a patient’s plan of care, outcomes including timeframes for achievement and continuity in collaboration with other health professionals and the patient (includes significant other when appropriate).  Evaluates progress toward expected outcomes and reviews and revises plan of care, in accordance with evaluation data (variance identification).
AutoNDA by SimpleDocs
Clinical Nursing. 4.2.1 Contributes to the formulation of care plans/clinical pathways in collaboration with the registered nurse. ∙ Accurately collects and reports data regarding the health and functional status of patients. ∙ Participates with the registered nurse, patient and family/carers in identifying expected health care outcomes and patient needs. ∙ Participates with the registered nurse in evaluation of progress of patients toward expected outcomes and reformulation of care plans/clinical pathway.
Clinical Nursing. 4.2.1 Carries out comprehensive and accurate nursing assessment of patients, plan and implement care and evaluate the achievement of identified outcomes: ∙ Uses a structured approach in the process of assessment and collection of data regarding the health and functional status of the patient. ∙ Analyses and interprets the data accurately. ∙ Collaborates with the patient and family/carers/significant other in identifying expected health care outcomes and patient needs. ∙ Formulates a patient’s plan of care, outcomes including timeframes for achievement and continuity in collaboration with other health professionals and the patient (includes significant other when appropriate). Subject: ∙ Evaluates progress toward expected outcomes and reviews and revises plan of care, in accordance with evaluation data (variance identification).
Clinical Nursing. 4.2.1 Carries out comprehensive and accurate nursing assessment of patients, plan and implement care and evaluate the achievement of identified outcomes: ∙ Uses a structured approach in the process of assessment and collection of data regarding the health and functional status of the patient. ∙ Analyses and interprets the data accurately. ∙ Collaborates with the patient and family/carers/significant other in identifying expected health care outcomes and patient needs. ∙ Formulates a patient’s plan of care, outcomes including timeframes for achievement and continuity in collaboration with other health professionals and the patient (includes significant other when appropriate). ∙ Evaluates progress toward expected outcomes and reviews and revises plan of care, in accordance with evaluation data (variance identification). Subject: 4.2.2 Manages effectively nursing care of patients within scope of competence : ∙ Organises workload to facilitate planned nursing care. ∙ Delegates to others activities commensurate with their abilities and standards for practice. ∙ Responds effectively in unexpected or rapidly changing situations ie. The deteriorating patient. ∙ Escalates issues of deteriorating patients to Unit Manager / After Hours Nurse Manager and Medical Officer ∙ Ensures all observations are undertaken and charted as per policy on MADDs chart.
Clinical Nursing. Contribute to the formation of care plans/clinical pathways in collaboration with the Registered Nurse; – Accurately collect and report data regarding the health and functional status of patients; – Participate with the registered nurse, patient and family/carers in identifying expected health care outcomes and patient needs; – Participate with the registered nurse in evaluation of progress of patients toward expected outcomes and reformulation of care plans/clinical pathway; – Manage nursing care of patients within the scope of enrolled nursing practice; – Implement planned nursing care to achieve identified outcomes; – Recognise and report changes in the health and functional status of patients to the registered nurse; – Ensure communication, reporting and documentation are timely and accurate; – Organise workload to facilitate planned nursing care for patients and reprioritise when appropriate with the registered nurse; – Provide support and care to patients within the scope of enrolled nursing; – Provide for the comfort needs of patients experiencing illness or dependence; – Ensure patient values, customs and spiritual beliefs are respected; – Contribute to the health education of patients to maintain and promote health; − Communicate with patients in an appropriate manner and environment to enable therapeutic outcomes. The following responsibilities apply to an Endorsed Enrolled Nurse only. The Endorsed enrolled nurse must provide evidence of Endorsement and also be deemed competent following completion of Drug Competency Assessment and/or completion of competencies under direct supervision in accordance with the Organisation Policy Enrolled Nurse Scope of Practice. – Enrolled Nurses with medication endorsement may when delegated by the Registered Nurse and in accordance with procedure administer S4 medications; – Enrolled nurses who have completed Medication Endorsement EN (Med) + S8 Competent may administer controlled S8 drugs under the direct supervision of a Registered Nurse or a Doctor under the strict guidelines and criteria as per the Organisational Policy – Enrolled nurses who have completed Medication Endorsement EN (Med) + IV Medication Competent may administer designated IV medications under the indirect supervision of a Registered Nurse or Doctor under the strict guidelines and criteria as per the organisational policy.
Clinical Nursing.  Carries out comprehensive and accurate nursing assessment of patients, plan and implement care and evaluate the achievement of identified outcomes  Uses a structured approach in the process of assessment and collection of data regarding the health and functional status of the patient.  Analyses and interprets the data accurately.  Collaborates with the patient and family/carers/significant other in identifying expected health care outcomes and patient needs.  Formulates a patient’s plan of care, outcomes including timeframes for achievement and continuity in collaboration with other health professionals and the patient (includes significant other when appropriate).  Evaluates progress toward expected outcomes and reviews and revises plan of care, in accordance with evaluation data (variance identification).  Manages effectively nursing care of patients within scope of competence;  Organises workload to facilitate planned nursing care.  Delegates to others activities commensurate with their abilities and standards for practice.  Responds effectively in unexpected or rapidly changing situations ie. The deteriorating patient. Escalates issues of deteriorating patients to Unit Manager / After Hours Nurse Manager and Medical Officer  Ensures all observations are undertaken and charted as per policy on MADDs chart.  Ensures that clinical activities within the xxxx and associated services remain within the hospital’s delineated role, and comply with the Clinical Guidelines under the Private Health Facilities Act.  Applies competent clinical practice which is evidenced based to ensure optimal health of the patient.  Assess and respond to clinical and nursing problems within the scope of practice.  Ensures contemporaneous documentation occurs. The entries are signed with printing of name and designation is applied after the entry.
Clinical Nursing. Carries out comprehensive and accurate nursing assessment of patients, plan and implement care and evaluate the achievement of identified outcomes: - Uses a structured approach in the process of assessment, collect data regarding the health and functional status of the patient; - Analyses and interprets the data accurately; - Collaborates with the patient and family/carers/significant other in identifying expected health care outcomes and patient needs; - Formulates a patient’s plan of care, outcomes including timeframes for achievement and continuity in collaboration with other health professionals and the patient (includes significant other when appropriate); - Evaluates progress toward expected outcomes and reviews and revises plan of care, in accordance with evaluation data (variance identification); - Effectively manages nursing care of patients within scope of competence; - Organises workload to facilitate planned nursing care; - Delegate s to others activities commensurate with their abilities and scope of practice; - Responds effectively in unexpected or rapidly changing situations. – Ensures that clinical activities within the xxxx and associated services remain within the hospital’s delineated role, and comply with the Clinical Guidelines under the Private Health Facilities Act; – Applies sound clinical practice which is evidenced based to ensure optimal health of the patient; and – Assess and respond to clinical and nursing problems within the scope of practice.
AutoNDA by SimpleDocs
Clinical Nursing. − Assist in the care of patients within the scope of Assistant in Nursing practice; − Implement planned care to achieve identified outcomes; − Recognise and report changes in the health and functional status of patients to the Registered Nurse; − Ensure communication, reporting and documentation are timely and accurate; − Organise workload and reprioritise when appropriate with the Registered Nurse; − Provide support and care to patients within the scope of Assistant in Nursing practice; − Provide for the comfort needs of patients experiencing illness or dependence; − Ensure patient values, customs and spiritual beliefs are respected; − Collaborate with the Registered nurse and members of the health care team in the provision of care; − Communicate with patients in an appropriate manner and environment to enable therapeutic outcomes; – Following demonstrated competence the Assistant in Nursing is able to perform the following: • Daily Hygiene Needs • Nutrition – Oral feeding • Xxxxx Xxxxx Measurement and reporting to Registered Nurse • Position, Mobilising and Weighing of Patients, • Escorting patients to Theatre following appropriate clinical handover , • Apply Xxx stockings, • Ensuring Infection Control practices are followed, and • Fluid Balance of Charting and reporting to Registered Nurse. • Risk management practices and safe systems of work • Monitoring and control of environmental factors in the workplace
Clinical Nursing. 4.2.1 Carries out comprehensive and accurate nursing assessment of patients, plan and implement care and evaluate the achievement of identified outcomes: ∙ Uses a structured approach in the process of assessment and collection of data regarding the health and functional status of the patient. ∙ Analyses and interprets the data accurately. ∙ Collaborates with the patient and family/carers/significant other in identifying expected health care outcomes and patient needs. ∙ Formulates a patient’s plan of care, outcomes including timeframes for achievement and continuity in

Related to Clinical Nursing

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Radiation Therapy/Chemotherapy Services This plan covers chemotherapy and radiation services. This plan covers respiratory therapy services. When respiratory services are provided in your home, as part of a home care program, durable medical equipment, supplies, and oxygen are covered as a durable medical equipment service.

  • Synchronization, Commissioning and Commercial Operation 4.1.1 The Power Producer shall give at least fifteen (15) days written notice to the SLDC / ALDC / DISCOM as the case may be, of the date on which it intends to synchronize the Power Project to the Grid System. 4.1.2 Subject to Article 4.1.1, the Power Project may be synchronized by the Power Producer to the Grid System when it meets all the connection conditions prescribed in the Grid Code and otherwise meets all other Indian legal requirements for synchronization to the Grid System. 4.1.3 The synchronization equipment and all necessary arrangements / equipment including Remote Terminal Unit (RTU) for scheduling of power generated from the Project and transmission of data to the concerned authority as per applicable regulation shall be installed by the Power Producer at its generation facility of the Power Project at its own cost. The Power Producer shall synchronize its system with the Grid System only after the approval of GETCO / SLDC / ALDC and GEDA. 4.1.4 The Power Producer shall immediately after each synchronization / tripping of generator, inform the sub-station of the Grid System to which the Power Project is electrically connected in accordance with applicable Grid Code. 4.1.5 The Power Producer shall commission the Project within SCOD. 4.1.6 The Power Producer shall be required to obtain Developer and/ or Transfer Permission, Key Plan drawing etc, if required, from GEDA. In cases of conversion of land from Agricultural to Non-Agriculture, the commissioning shall be taken up by GEDA only upon submission of N.A. permission by the Power Producer. 4.1.7 The Power Producer shall be required to follow the Forecasting and Scheduling procedures as per the Regulations issued by Hon’ble GERC from time to time. It is to clarify that in terms of GERC (Forecasting, Scheduling, Deviation Settlement and Related Matters of Solar and Wind Generation Sources) Regulations, 2019 the procedures for Forecasting, Scheduling & Deviation Settlment are applicable to all solar generators having combined installed capacity above 1 MW connected to the State Grid / Substation including those connected via pooling stations.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Speech Therapy This plan covers speech therapy services when provided by a qualified licensed • loss of speech or communication function; or • impairment as a result of an acute illness or injury, or an acute exacerbation of a chronic disease. Speech therapy services must relate to: • performing basic functional communication; or • assessing or treating swallowing dysfunction. See Autism Services when speech therapy services are rendered as part of the treatment of autism spectrum disorder. The amount you pay and any benefit limit will be the same whether the services are provided for habilitative or rehabilitative purposes.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!